Presentation
Bridges to Industry (Webinar Edition): Helena Roura, PhD, Medical Scientific Liaison (MSL) at UCB and IRB Barcelona Alumni
The next session of Bridges to Industry is on 15th December 2020!
Join us in the next meet & greet session organized by Innovation Department to meet our invited speaker: Helena Roura, PhD, Medical Scientific Liaison (MSL) at UCB and IRB Barcelona Alumni.
Helena Roura will share her experience as an MSL in the industrial sector and explain how her position contributes to generating value in the drug development process. In this regard, she will give an overview of her involvement in two pharmaceutical companies, namely Novartis and UCB.
Bridges to Industry is a meet & greet programme set up by the Innovation Department. It aims to provide you with the opportunity to meet key professionals in the bio sector to expand and/or consolidate your network. Schedule of the session:
- Highlights of the drug discovery value chain
- Presentation by the Invited Speaker
- Open floor to participants for Q&A
- Closing remarks
Sessions are open to all IRB members (limited places). In addition, a number of places are reserved for IRB Barcelona alumni.
If you wish to participate in this session, please register before 10 December (Registration Form) Alumni members please contact us at innovation@irbbarcelona.org. A confirmation email together with the link to the event will be sent after the registration deadline.
Organizer: IRB Innovation Department
Speaker: Helena Roura, PhD, Medical Scientific Liaison (MSL) at UCB and IRB Barcelona Alumni
Date: Tuesday, 15 December 2020, 17:00-18:00
Place: Webinar Edition - Zoom link will be sent to selected participants
Language: English
Audience: Open to the entire IRB Barcelona community (Limited places available)
With the support of:
Speakers
Helena Roura, PhD
Medical Scientific Liaison at UCB and IRB Barcelona Alumni
Helena studied Pharmacy at the University of Barcelona (UB), did her PhD at the Institute for Research in Biomedicine (IRB Barcelona) and has an MBA from ENEB Business School.
Her PhD at IRB Barcelona was focused on biomedical studies of gene translation and its regulation, and the development of related therapeutic strategies. After finishing her PhD in 2018, she started working at the Medical Affairs Department of Novartis Pharmaceuticals. In 2019, she was promoted to Medical Science Liaison (MSL) for the Madrid area. In 2020, she moved to UCB Pharma in Barcelona